Institutional News

Favaloro Cardiovascular Symposium 2025

solaci
solaci
855
0

The Latin American Society of Interventional Cardiology invites you to participate in the Favaloro Cardiovascular Symposium 2025, which will take place from September 11 to 12, 2025, at the Intercontinental Hotel in Buenos Aires, Argentina.

The event is endorsed by SOLACI and will feature a rich and diverse scientific program. Various scientific activities, simultaneous sessions, and live case transmissions from Rotterdam and the Favaloro Hospital will be conducted. Topics will range from prevention to heart transplantation, always highlighting the latest innovations and technological advances.

Additionally, distinguished professors from around the world will join to share their knowledge with the audience.

More information

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
EuroPCR 2025 | DANAMI-3-DEFER: 10-Year Results of Deferred vs. Conventional Stenting in STEMI Patients
Next article
Transcatheter Tricuspid Valve Replacement: 1-Year Outcomes
solaci
solaci

More articles by this author

Fellow’s Corner 2026 – Submit Your Clinical Case

solaci - 0
Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

solaci - 0
The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

solaci - 0
Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Institutional News

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching...
solaci -
SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Dr. Juan Manuel Pérez - 0
Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Dr. Andrés Rodríguez - 0
Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Dr. Omar Tupayachi - 0
Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...